Results 51 to 60 of about 14,545 (184)

Association of Glucagon‐Like Peptide—1 Receptor Analogues and Laryngeal Symptoms in Obese Adults

The Laryngoscope, EarlyView.
Table 1 succinctly quantifies the time‑dependent association between GLP‑1RA/GIP therapy and laryngeal symptoms, demonstrating modest but statistically robust increases in outcomes such as cough and voice/resonance disorders by 6 months. It provides clinically actionable absolute risks, odds ratios, and hazard ratios that can directly inform counseling,
Priyanka Shah, David Kayekjian, Shaun A. Nguyen, Kirsten Meenan, Ashli K. O’Rourke   +4 more
wiley   +1 more source

Therapeutic JAK Inhibition in Idiopathic Subglottic Stenosis

The Laryngoscope, EarlyView.
Three patients with idiopathic subglottic stenosis and rheumatoid arthritis began JAK inhibitor therapy, after which the mean surgical‐free interval between endoscopic dilations rose from 317 to 631 days and the annualized dilation rate fell from 1.24 to 0.38 per patient‐year. Figure 2 shows this as a per‐patient timeline.
Riley M. Larkin, Ioan Lina, Julianna Kostas, Caroline Christmann, Kevin Byram, Alexander Gelbard   +5 more
wiley   +1 more source

Is gastroparesis a gastric disease?

, 2019
Background: Gastroparesis is a digestive syndrome characterized by delayed gastric emptying (GE) and by symptoms that are suggestive of gastroduodenal motor disorders. There are three grades of gastroparesis of increasing severity: (a) mild gastroparesis;
De Giorgio R., Cremon C., Cogliandro R. F., Stanghellini V., Rizzoli G., Barbara G., Bellacosa L., Lara Bellacosa, Cesare Cremon, Giovanni Barbara, Rosanna F. Cogliandro, Giada Rizzoli, Vincenzo Stanghellini, Roberto De Giorgio   +13 more
core   +1 more source

Association between Gastroparesis and the Pancreatic Cancer Risk and In-Hospital Mortality: A Nationwide Analysis from the United States

The Korean Journal of Gastroenterology
Background/Aims: Pancreatic cancer is a highly lethal malignancy often diagnosed at an advanced stage. Gastroparesis, marked by delayed gastric emptying, may be a potential risk factor or early indicator.
Bobak Moazzami, Dariush Shahsavari, Zohyra E. Zabala, Raguraj Chandradevan, Navkiran Randhawa, Catarina Cutter, Humberto Sifuentes, Subbaramia Sridhar   +7 more
doaj   +1 more source

Inducible Laryngeal Obstruction in Hypermobile Patients

The Laryngoscope, EarlyView.
Patients with hypermobile Ehlers‐Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD) who screened positive for inducible laryngeal obstruction (ILO) reported significantly greater voice, cough, swallowing, gastrointestinal, and mast cell‐related symptoms than those without ILO. Chronic cough, dysphagia, and elevated mast cell symptom score
Stacey M. Menton, DeLisa Fairweather, Frances C. Wilson, Derek J. Zangerle, Emma F. Murphy, Ashley A. Darakjian, Chandler C. Thompson, Shilpa N. Gajarawala, Dacre R. T. Knight, Katelyn A. Bruno, Amy L. Rutt   +10 more
wiley   +1 more source

Frequency of gastroptosis and gastroparesis in children with treatment-resistant dyspepsia and duodenogastric reflux: a prospective study

The Turkish Journal of Pediatrics
Background. Studies on gastroptosis and gastroparesis in children are limited. This prospective study aimed to evaluate the frequency of gastroptosis and gastroparesis and their association with duodenogastric reflux (DGR) and treatment-resistant ...
Melike Arslan, Edibe Gözde Başaran, Coşkun Fırat Özkeçeci, Bekir Nihat Doğrul, Necati Balamtekin   +4 more
doaj   +1 more source

Gastric Electrical Stimulation: Role and Clinical Impact on Chronic Nausea and Vomiting

Frontiers in Neuroscience, 2022
Gastric electrical stimulation (GES) is currently used as an alternative treatment for medically refractory gastroparesis. GES has been initially developed to accelerate gastric motility, in order to relieve the symptoms of the patients.
Heithem Soliman, Heithem Soliman, Guillaume Gourcerol   +2 more
doaj   +1 more source

The Gut–Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism‐Based Precision Medicine

Movement Disorders, EarlyView.
Abstract Gastrointestinal dysfunction is increasingly recognized as a core feature of Parkinson's disease (PD), affecting quality of life, nutrition, medication response, and potentially the earliest stages of pathogenesis. This perspective traces the evolution of the gut from a neglected source of non‐motor symptoms to a central component of ...
Filip Scheperjans, Per Borghammer, Ronald F. Pfeiffer, Silke Appel‐Cresswell, Ali Keshavarzian   +4 more
wiley   +1 more source

Gastroparesis and Systemic Lupus Erythematosus: A Propensity Score‐Matched Study of US National Database Analysis

JGH Open
Introduction While gastrointestinal involvement is a common manifestation of systemic lupus erythematosus (SLE), the association between gastroparesis and SLE remains unclear.
Noppachai Siranart, Pannathorn Nakaphan, Thanathip Suenghataiphorn, Panisara Fangsaard, Tanattida Phanthong, Patavee Pajareya, Somkiat Phutinart, Pawaris Tirakunwichcha, Suwit Paksin, Pornnicha Sowalertrat, Sakkarin Chirapongsathorn, Kittithat Tantitanawat   +11 more
doaj   +1 more source

Diabetic Gastroparesis [PDF]

, 2015
According to the 2014 Centers for Disease Control (CDC) 9.3% of the United States Population have diabetes (National diabetes statistics report, “2014, p.1). One of the complications of diabetes is gastroparesis. Gastroparesis is “a delay in the emptying
Burris Welch, Noreen
core